Gemini Space Station Inc vs Koninklijke Philips NV — how do they compare? Gemini Space Station Inc trades at $4.29 (market cap $579.55M), while Koninklijke Philips NV trades at $24.4 (market cap $23.52B). The key difference: Koninklijke Philips NV is far larger — about 40.6× Gemini Space Station Inc's market cap, and Koninklijke Philips NV pays a 4.17% dividend while Gemini Space Station Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Gemini Space Station Inc for 14 Days and Koninklijke Philips NV for 84 Days on average.
| GEMI | PHG | |
|---|---|---|
Market Cap | $579.55M | $23.52B |
Volume | 1,882,406 | 1,635,069 |
Sector | Financials | Health |
52-Week High | $25.41 | $32.91 |
52-Week Low | $3.54 | $23.81 |
Typical Hold Time | 14 Days | 84 Days |
Enterprise Value | $558.57M | $29.87B |
Dividend Yield | — | 4.17% |
Signals from Pluang's Aura AI — not financial advice
Gemini Space Station (GEMI) trades at $4.49, down 3.85% amid bearish technical signals despite recent 31% surge. The company shows concerning fundamentals with negative gross profit margin of -70.25% and net income margin of -250.13% for 2025. Revenue grew 37% YoY in Q2 2026 to $207M, but losses persist with $517M net loss. Analyst consensus is mixed with 33% buy ratings and $5.33 price target, while technical indicators show oversold conditions with RSI at 16.87.
GEMI presents high-risk speculation with significant operational challenges despite revenue growth. The stock's viability depends on reversing deep losses and achieving profitability. Near-term catalysts include SEC's tokenized stock trading pathway, but class action lawsuits and persistent cash burn pose substantial downside risk. Current valuation at 2.75 P/S appears stretched given negative margins.
PHG trades at $24.09, down 0.25% with a bearish technical signal. The company shows improving fundamentals with three consecutive quarterly EPS beats and a return to profitability in 2025 (net income $895M). Recent news highlights innovation in healthcare technology including new product launches and AI partnerships. Valuation metrics appear reasonable with P/E of 18.94 and P/S of 1.18.
PHG presents a mixed outlook with strong operational recovery but technical weakness. The investment case hinges on continued earnings momentum and successful execution of healthcare technology initiatives. Key risks include competitive pressures and potential cybersecurity vulnerabilities following recent hacking incidents. Analyst consensus leans neutral with 36% buy ratings versus 64% hold.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Gemini Space Station Inc is the parent company of the Gemini crypto ecosystem, founded by Cameron and Tyler Winklevoss. It operates as a regulated digital asset exchange and custodian, providing a platform for individuals and institutions to trade, store, and stake cryptocurrencies while serving as a trusted bridge between legacy finance and the decentralized web.
Read more on GEMI →Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →